ReviewFrontiers in pharmacology2019

Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis.

Andre Schultz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.